Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Sharps Technology Inc (STSS)

  • SEC News
  • Jan. 23, 2026, 11:12 UTC
  • 1
  • 0 comments

New Form SCHEDULE 13G/A - Sharps Technology Inc. Filed: 2026-01-23 AccNo: 0001062993-26-000395 Size: 11 KB

Comment Full text

IX Biopharma LTD. (42C)

  • SEC News
  • Jan. 23, 2026, 09:45 UTC
  • 2
  • 0 comments

Equity Listing - Ordinary Shares: Issue and Allotment of Shares Pursuant to Exercise of Warrants

Comment Full text

IHH Healthcare Berhad (Q0F)

  • SEC News
  • Jan. 23, 2026, 09:35 UTC
  • 1
  • 0 comments

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Comment Full text

TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED (T14)

  • SEC News
  • Jan. 23, 2026, 09:15 UTC
  • 1
  • 0 comments

Mandatory Cash Dividend/ Distribution:

Comment Full text

RedHill Biopharma (RDHL)

  • SEC News
  • Jan. 22, 2026, 21:08 UTC
  • 3
  • 0 comments

New Form S-8 - RedHill Biopharma Ltd. Filed: 2026-01-22 AccNo: 0001178913-26-000206 Size: 850 KB

Comment Full text

RedHill Biopharma (RDHL)

  • SEC News
  • Jan. 22, 2026, 21:06 UTC
  • 1
  • 0 comments

New Form F-1/A - RedHill Biopharma Ltd. Filed: 2026-01-22 AccNo: 0001178913-26-000204 Size: 677 KB

Comment Full text

SOBR Safe, Inc. (SOBR)

  • SEC News
  • Jan. 22, 2026, 19:49 UTC
  • 1
  • 0 comments

New Form 424B3 - SOBR Safe, Inc. Filed: 2026-01-22 AccNo: 0001477932-26-000335 Size: 245 KB

Comment Full text

RAMI LEVY REAL ESTATE LTD (RLRE)

  • SEC News
  • Jan. 22, 2026, 19:31 UTC
  • 1
  • 1 comments

Обновление данных компании RAMI LEVY REAL ESTATE LTD (7 изменений)

Comment Full text

cbdMD Inc. (YCBD)

  • SEC News
  • Jan. 22, 2026, 14:31 UTC
  • 2
  • 0 comments

New Form S-1 - cbdMD, Inc. Filed: 2026-01-22 AccNo: 0001437749-26-001692 Size: 816 KB

Comment Full text

Immuneering Corporation (IMRX)

  • SEC News
  • Jan. 22, 2026, 14:03 UTC
  • 1
  • 0 comments

New Form SCHEDULE 13G/A - Immuneering Corp Filed: 2026-01-22 AccNo: 0001790340-26-000020 Size: 7 KB

Comment Full text
  • Previous
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next

Search

News categories

  • Technical Exchange News(10841)
  • Event(2204)
  • SEC News(187793)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124243)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin